Concentration of Risk

ELI LILLY & Co

Medium

LLY · NYSE · Pharmaceutical Preparations · CIK 0000059478

Latest filing: 10-K · 2026-02-12

Customer concentration

Significant Customers note · revenue dependency

Medium
Top exposure
16%
Three Largest Wholesalers
Flat

Click a point to open the SEC source

FY250%4%8%12%16%

Geographic concentration

Segment reporting · geographic revenue

High
Top exposure
66.7%
U.S
-0.7pp YoY

Click a point to open the SEC source

FY23FY24FY250%20%40%60%80%

Supplier concentration

Risk Factors · supply chain dependency

Low
Dependency
Single source
Single sourceNamed
Qualitative disclosure — no % quantified (informational, not scored)
Flat
FY25

Qualitative dependency level by filing year.

Product concentration

ASC 275 · disclosed dependence on a specific product or service

Low
Top exposure
<10%
No disclosure detected
Flat

Credit concentration

ASC 825 · concentration of credit risk note

Low
Receivables
20%
Each of Three Largest Wholesalers (individually)
Flat

Click a point to open the SEC source

FY250%5%10%15%20%